Literature DB >> 16509857

Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated?

Xiong-Zhi Wu1, Dan Chen.   

Abstract

Helicobacter pylori can be detected in liver tissue resected from patients with hepatocellular carcinoma. Conflicting reports regarding the relationship between H. pylori and hepatocellular carcinoma mean it is uncertain whether H. pylori acts as a troublemaker, co-risk factor or innocent bystander to the development of hepatocellular carcinoma. Clinical studies in patients without known causes of hepatocellular carcinoma are important to discover whether H. pylori is involved in the carcinogenesis of hepatocellular carcinoma. High quality prospective studies in patients with hepatocellular carcinoma, hepatitis C virus infection and no cirrhosis are needed to determine whether H. pylori is a co-risk factor for hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16509857     DOI: 10.1111/j.1440-1746.2006.04245.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

Review 1.  Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysis.

Authors:  Shi-Ying Xuan; Yong-Ning Xin; An-Jin Chen; Quan-Jiang Dong; Xin Qiang; Ning Li; Ming-Hua Zheng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 2.  Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.

Authors:  Xing-Nan Pan; Lian-Qiu Zheng; Xiao-Huan Lai
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

3.  Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States.

Authors:  Perumal Vivekanandan; Michael Torbenson
Journal:  Hum Pathol       Date:  2007-10-18       Impact factor: 3.466

Review 4.  The Association between Helicobacter pylori Infection and Chronic Hepatitis C: A Meta-Analysis and Trial Sequential Analysis.

Authors:  Juan Wang; Wen-Ting Li; Yi-Xiang Zheng; Shu-Shan Zhao; Ning Li; Yan Huang; Rong-Rong Zhou; Ze-Bing Huang; Xue-Gong Fan
Journal:  Gastroenterol Res Pract       Date:  2016-01-24       Impact factor: 2.260

5.  Association Between Acid-Suppressive Agents' Use and Risk of Hepatocellular Carcinoma.

Authors:  Hsiu C Lin; Huan Y Hsu; Hsiu L Lin; Yow S Uang; Yi Ho; Li H Wang
Journal:  Dose Response       Date:  2020-04-13       Impact factor: 2.658

6.  The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis.

Authors:  Wei Xu; Xiaochong Zhou; Minyue Yin; Jingwen Gao; Zhen Weng; Chunfang Xu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

7.  Decreased risk of liver and intrahepatic cancer in non-H. pylori-infected perforated peptic ulcer patients with truncal vagotomy: a nationwide study.

Authors:  Shih-Chi Wu; Han-Tsung Cheng; Yu-Chun Wang; Chia-Wei Tzeng; Chia-Hao Hsu; Chih-Hsin Muo
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.